Clinical Trials Browser

Phase 1/2 × Breast Neoplasms, Male × denileukin diftitox × Clear all

NCT00425672 2018-12-05

ONTAK® in Treating Patients With Advanced Breast Cancer That Did Not Respond to Previous Treatment

Phase 1/2 Completed

15 enrolled 13 charts

Breast Neoplasms, Breast Neoplasms, Male